Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
about
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and AdolescenceLifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDCurrent Management of NAFLDManagement of non-alcoholic fatty liver disease in 2015Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentLifestyle interventions for the treatment of non-alcoholic fatty liver diseaseRole of diet on non-alcoholic fatty liver disease: An updated narrative reviewExercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryHigh-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver DiseaseControversies in the Diagnosis and Management of NAFLD and NASH.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.Advances in the diagnosis and treatment of nonalcoholic steatohepatitis.Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study.Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C.Review article: the management of paediatric nonalcoholic fatty liver disease.Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults.Effect of caloric restriction and AMPK activation on hepatic nuclear receptor, biotransformation enzyme, and transporter expression in lean and obese mice.The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients.Treating NAFLD in OLETF rats with vigorous-intensity interval exercise trainingCytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.Practical approach to non-alcoholic fatty liver disease in patients with diabetes.Hepatic steatosis is associated with lower levels of physical activity measured via accelerometryEthnicity and nonalcoholic fatty liver diseasePhysical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease.Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver DiseaseFatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment.Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?Pathogenesis and Prevention of Hepatic Steatosis.Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study.Objectively Quantified Physical Activity and Sedentary Behavior in Predicting Visceral Adiposity and Liver FatVitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?Does physical inactivity cause nonalcoholic fatty liver disease?Cryptogenic chronic hepatitis and its changing guise in adults.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
P2860
Q26744488-8261D1CD-5FD5-444B-BD1A-7FEBC32056E2Q26748608-32408570-8653-49E6-96C2-026050269B15Q26752487-170C8C08-4EC7-495B-9958-187F630FAF66Q26752729-70B4AFB5-AA0B-4D7D-8E94-23BD7E57806CQ26771148-91DAA31F-4125-4AD6-9839-74221CF9CA25Q26852019-AFD0D046-5BCE-4B22-A1E4-83BA0661B633Q26862945-13E7D194-E046-4EE2-860D-61F23F3C4A51Q27000333-E7282C36-5724-4A3D-9D28-DFB630158454Q28072762-4A9ECB95-6C6A-43C4-A993-C59DE07C457CQ30362727-03306350-214D-4658-A6A6-71DFA137661AQ30412296-359176E7-216F-4B5A-A753-2E0B8E8F9061Q30412771-D04867F6-30C5-4852-89AA-AC9C54A2EB7CQ33568261-104321D0-4CDC-4013-8491-C46DF66C12DBQ33582176-6C8D55B2-E4B6-4DF9-A5A1-94D277F09C2CQ33891750-D3C18BB0-18D7-43AD-8726-AF2900437E5DQ34024582-E7F15DEC-712D-4231-B5A2-4AE3B8524D09Q34168532-CA2983C2-2F00-4AA7-8FD8-ADD342BFD72BQ34335564-0390BD21-3B13-40C0-944F-E92CE398F450Q34440962-303672C4-801C-487A-ACDD-F9FF9341FF01Q34460342-25E5EB65-490E-46EE-AEC0-3F4C9322A112Q34478741-8B0EF034-3396-4A65-BBC8-3BC2AFFB77C2Q34522981-DC3E2CF2-DB99-4B8E-BF44-5FC133C92D0DQ34791448-E789D420-64D4-4189-8157-30D94F16F793Q35064093-12BDEEF3-4B2E-46AD-B5A2-496E754BEE42Q35561693-53107A41-4128-45BF-984C-B2FD6B5CDF1FQ35655694-698837F9-F17A-4094-8528-B5399CBF9D54Q35754063-7D8AEDAA-60B1-48FE-B850-0F7F2AC728E0Q35926253-FFD6A722-F8B0-4000-864B-ED54699349AEQ36116130-7CEE7057-9B3A-4EFB-AC3D-1627A5B10788Q36279434-67985573-06B7-4D5D-8C5F-32D93D8E1868Q36367014-3B120A63-1532-44AA-BABB-9DF4BC2FE1D0Q36461013-8B574885-F2E2-4D31-9AB5-CAC17B7EBB4AQ36812508-A75F66D7-A33E-4487-A1EA-ABBB9EB2745AQ37251885-6450F02A-A2A7-41AC-8530-83177FCA5A13Q37335236-6A18FC9B-23F6-4A03-8D8F-DD6CA772F713Q37715451-2A7DB566-D46D-4D29-B95B-FA2C52C771AEQ37874856-897AECCD-D8A9-4B99-B275-F3336F889219Q37885803-AC0F31D9-E7C6-4849-87A4-8950D8FE68F0Q37978785-FB7FE892-5F3B-495F-8DAA-0060188E63D6Q38020492-DEF4A8D4-909B-45C4-B895-B8D41A933D7F
P2860
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Physical activity recommendati ...... alcoholic fatty liver disease.
@ast
Physical activity recommendati ...... alcoholic fatty liver disease.
@en
Physical activity recommendati ...... alcoholic fatty liver disease.
@nl
type
label
Physical activity recommendati ...... alcoholic fatty liver disease.
@ast
Physical activity recommendati ...... alcoholic fatty liver disease.
@en
Physical activity recommendati ...... alcoholic fatty liver disease.
@nl
prefLabel
Physical activity recommendati ...... alcoholic fatty liver disease.
@ast
Physical activity recommendati ...... alcoholic fatty liver disease.
@en
Physical activity recommendati ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P356
P1476
Physical activity recommendati ...... alcoholic fatty liver disease.
@en
P2093
Anna Mae Diehl
Elizabeth M Brunt
Jeanne M Clark
Jeffrey B Schwimmer
Kristin D Kistler
NASH CRN Research Group
P2860
P304
460-8; quiz 469
P356
10.1038/AJG.2010.488
P407
P577
2011-01-04T00:00:00Z